T
Tempo Pharmaceuticals
Tempo Pharmaceuticals is a biotechnology company based in Madrid, Spain
About Tempo Pharmaceuticals
Tempo Pharmaceuticals, a biopharmaceutical company, focused on developing nanoparticle-based drugs designed to enhance the efficacy and safety of therapeutics. The firm secured $8.1 million in Series B financing to advance its preclinical pipeline of multi-compartmental, nanoparticle-based drugs.
The company's approach centers on creating intelligently designed, multi-compartmental nanoparticles. These particles have the potential to significantly improve how existing and new drugs work while reducing their side effects. This technology aims to address challenges in drug delivery and effectiveness across various therapeutic areas.
Proceeds from its financing rounds are allocated to accelerating the development of its preclinical pipeline. By focusing on these novel drug delivery systems, Tempo Pharmaceuticals aims to bring forward a new class of treatments with improved therapeutic profiles.
Source: Dealroom company dataAt a glance
- Headquarters
- Madrid, Spain
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Tempo Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Tempo Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.